Elanco received USDA approval for BEFRENA® developed for the treatment of canine allergy and atopic dermatitis. Often a chronic and often life-disrupting condition, BEFRENA™ helps relieve itch and discomfort, improving quality of life for both dogs and their owners.

To ensure the name aligned with therapeutic intent, emotional resonance, and regulatory requirements, Elanco partnered with Brandsymbol to lead the end-to-end naming process, from strategy and creative development through validation.

The selected name, BEFRENA®, was designed to evoke the bond between dogs and their owners—“man’s best friend”—while conveying ease, tranquility, and relief. The name aligns with a therapy intended to help dogs get back to comfortable, happy daily living, and owners regain peace of mind.

Elanco successfully trademarked BEFRENA® and received USDA approval, reinforcing Brandsymbol’s role as a trusted partner in Animal Health branding, helping clients create names that balance emotional storytelling, strategic fit, and regulatory readiness.

Learn more about FAQ’S for drug information for animal health products.

Elanco Announces USDA Approval of BEFRENA™ for Canine Allergic and Atopic Dermatitis.